Navigation Links
Raptor Pharmaceuticals Provides Update on Targeting Platforms
Date:11/6/2008

Enters Collaboration on Receptor Associated Protein (RAP)

Supports NeuroTrans(TM) Platform with Japanese Patent

NOVATO, Calif., Nov. 6 /PRNewswire-FirstCall/ -- Raptor Pharmaceuticals Corp. ("Raptor" or the "Company") (OTC Bulletin Board: RPTP), today announced updates on its preclinical program which utilizes drug-targeting platforms derived from the human receptor-associated protein ("RAP") and related proteins. The Company signed a collaborative research agreement with the Brigham and Women's Hospital involving the characterization of certain modified RAP proteins. At the Hospital, this research will be conducted in the laboratory of Dr. Stephen Blacklow. The Company has also announced today a patent issuance in Japan relating to the NeuroTrans(TM) program.

The collaborative research with Brigham and Women's Hospital focuses on RAP sequence variants engineered for improved binding affinity and enhanced stability in complex with receptors. Under terms of the agreement, the Blacklow Laboratory, a substantial contributor to the study of RAP and its interactions, and researchers at Raptor will test RAP sequence variants designed to withstand temperatures, pH and other conditions that normally cause native receptor complexes to fail.

Todd C. Zankel, Ph.D., Chief Scientific Officer of Raptor, commented, "We are thrilled with the opportunity to work with Dr. Stephen Blacklow's lab to develop effective RAP-based sequence variants that could increase the utility of RAP-based targeting platforms and potential therapeutics. RAP-based peptides engineered to withstand certain conditions, such as low pH, may bind better and demonstrate enhanced biological potency compared to proteins or peptides derived from the naturally occurring RAP sequence and will complement our growing in-house set of targeting peptides."

Raptor also announced that the Patent Office of Japan will issue Raptor's patent application 2003-515208 entitled "Compositio
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
2. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
3. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
4. Raptor Pharmaceuticals Provides Update of Product Programs
5. Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Societys Eighth Annual Meeting (November 13-15, 2008; Bethesda, Maryland)
6. Mpex Pharmaceuticals Announces Initiation of a Phase 2 Clinical Trial of Aerosol MP-376 in COPD
7. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
8. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
9. Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor
10. Minster Pharmaceuticals Plc Announces Positive Results from Phase II Trial of Migraine with Aura
11. Addrenex Pharmaceuticals Initiates Phase 2 Trial on Its Novel Hypertension Drug, ADX415
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... According to a new market research report ... Synthetic, Fibrin, Collagen, Gelatin, Cyanoacrylate, Polymeric, Polyurethane), by Application ... 2020", published by MarketsandMarkets, the global Surgical Sealants and ... 2020, growing at a CAGR of 9.2% during the ... 119 market T ables and 29 ...
(Date:7/1/2015)... , July 1, 2015  Unilife Corporation (NASDAQ: ... and supplier of injectable drug delivery systems, announced today ... as of June 30, 2015. This amendment removed a ... million in cash receipts from customers during the six ... adjustments to any of the terms of the debt ...
(Date:7/1/2015)... , July 1, 2015  LabStyle Innovations Corp. ... today announced the appointment of Todd Durniak as Senior ... Durniak brings to LabStyle over 20 years of ... as the Vice President and General Manager of ... delivering insulin supplies through durable medical equipment (DME) ...
Breaking Medicine Technology:Surgical Sealants and Adhesives Market Worth $2.64 Billion by 2020 2Surgical Sealants and Adhesives Market Worth $2.64 Billion by 2020 3Surgical Sealants and Adhesives Market Worth $2.64 Billion by 2020 4Unilife and OrbiMed Amend Debt Financing Agreement 2Unilife and OrbiMed Amend Debt Financing Agreement 3LabStyle Innovations Appoints Senior VP & General Manager in U.S. for the Dario Diabetes Management Solution 2LabStyle Innovations Appoints Senior VP & General Manager in U.S. for the Dario Diabetes Management Solution 3LabStyle Innovations Appoints Senior VP & General Manager in U.S. for the Dario Diabetes Management Solution 4
... Inc. announced today that it has entered into ... to provide Otsuka with access to BioWa,s POTELLIGENT® ... of their antibody therapeutics with enhanced antibody-dependent cellular ... License was initiated in May, 2007 with Takeda ...
... PEAK Surgical, Inc. and Medtronic, Inc. (NYSE: MDT ... Technologies business at Medtronic exclusive rights for global distribution ... Adenoid) tissue dissection device for the ear, nose, and ... is a major step toward our goal of capturing ...
Cached Medicine Technology:BioWa Announces Second Japanese License of POTELLIGENT(R) Technology to Otsuka Pharmaceutical 2PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear, Nose, and Throat Market 2PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear, Nose, and Throat Market 3
(Date:7/1/2015)... Livonia, Mich. (PRWEB) , ... July 01, 2015 ... ... the transition of Catholic sponsorship complete, St. Joseph’s Health, located in Syracuse, N.Y., ... "With the closing today, we have gained an admirable and important partner committed ...
(Date:7/1/2015)... , ... July 01, 2015 , ... ... Biomedical Sciences at Georgia State University and a Georgia Research Alliance Eminent Scholar ... develop novel anti-inflammatory therapeutics against middle-ear infections. , The grant from the National ...
(Date:7/1/2015)... ... July 01, 2015 , ... Sir Fazle Hasan Abed, BRAC’s ... Prize today. Sir Fazle has been recognised for his outstanding contribution to enhancing the ... Ken Quinn, President of the World Food Prize Foundation, announced this year’s winner at ...
(Date:7/1/2015)... ... July 01, 2015 , ... The federal ... ( http://www.injurybeacon.com/levaquin/lawsuit/ ) has granted the Defendants’ Motion for Summary Judgment. According to ... on June 26th, the Court rejected the Plaintiff’s assertion that one manufacturer ...
(Date:7/1/2015)... New York, NY (PRWEB) , ... July 01, 2015 , ... ... around which DNA is wound, histones, remain constant in the brain, never changing after ... Sinai have discovered that histones are steadily replaced in brain cells throughout life – ...
Breaking Medicine News(10 mins):Health News:St. Joseph’s Health Now a Member of Trinity Health 2Health News:St. Joseph’s Health Now a Member of Trinity Health 3Health News:St. Joseph’s Health Now a Member of Trinity Health 4Health News:Institute for Biomedical Sciences Researcher Gets $1.6 Million to Develop Anti-Inflammatory Drug 2Health News:Sir Fazle Hasan Abed Receives World Food Prize 2Health News:Sir Fazle Hasan Abed Receives World Food Prize 3Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 3Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 3Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 4
... Conference Foundation Prize in Pediatric, Oncology for Novel Approaches for ... ... SUNNYVALE, Calif., April 3, 2008 Xoft consulting,medical director, Mark ... Oncology for his research focused on novel,approaches for using KV X-ray-based ...
... Kelly Ripa Team Up to Promote New Appliance Line,s European, Style ... ... -, NEW YORK, April 3, 2008 Known and admired for ... is tapping Kelly Ripa for the North America launch of its new,premium ...
... within primary breast tumors can empower cells that break ... organs, researchers report in the April 4th Cell, a ... hundreds of human breast tumors, the researchers found evidence ... breast cancer cells for metastasis to the lungs, one ...
... Prenatal syphilis screening, recommended by the Centers ... health authorities, is critical to preventing still births ... mothers. A study published in the April ... that state Medicaid statistics, when used to determine ...
... Selective,Insurance Group, Inc. announced the following ... America ("Selective"):, Yanina Hupka (Sparrowbush, NY), ... she served as assistant vice president,and assistant ... 2000 as a,senior reinsurance accountant. Before coming ...
... and unstated feelings about Clinton, BOSTON, April 3, ... "insecure" than they are typically willing,to admit, according to ... "confidence" voters express about the U.S. Senator from New,York ... does not appear to be,very deep., Emotion Mining, ...
Cached Medicine News:Health News:Xoft Medical Director Recognized by Gotham Prize for Cancer Research 2Health News:Xoft Medical Director Recognized by Gotham Prize for Cancer Research 3Health News:Europe's Leading Premium Appliance Brand Taps America's Most Stylish, Multi-Tasking Mom to Launch New Appliance Line in North America 2Health News:Europe's Leading Premium Appliance Brand Taps America's Most Stylish, Multi-Tasking Mom to Launch New Appliance Line in North America 3Health News:Europe's Leading Premium Appliance Brand Taps America's Most Stylish, Multi-Tasking Mom to Launch New Appliance Line in North America 4Health News:Human breast tumors' 'microenvironment' primes them for metastasis 2Health News:Prenatal syphilis screening rates: Are they being accurately reported? 2Health News:Voting for Clinton Evokes Deep-Seated Feelings of Insecurity 2
... The ABL800 FLEX is a fully ... most advanced blood gas analyzer along ... gives you the freedom to focus ... FLEX provides features that are essential ...
Flatbed Agitator....
Flatbed Agitator....
... platelet agitators offer a wide range of ... the drawer storage platform to agitate smoothly, ... wear down and squeak. Sturdy, one-piece perforated ... air circulation for your platelets., ,i.Series platelet ...
Medicine Products: